FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation

Article Link: FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation

Dublin, Ireland – 2 July 2020: Cosmo Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has approved Byfavo (remimazolam injection) for the induction and maintenance of procedural sedation in adults undergoing…

Source: FDA New Drug Approvals